IRVINE, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives ...
IRVINE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the ...
IRVINE, Calif., May 21, 2018 /PRNewswire/ -- Inari Medical, Inc., announced today the FlowTriever System has received FDA 510(k) clearance for the treatment of pulmonary embolism ("PE"). This ...
The FlowTriever percutaneous mechanical thrombectomy system (Inari Medical) is safe and provides immediate benefits to patients with acute pulmonary embolism (PE), interim results of the real-world ...
IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...
Phoenix, AZ (May 19, 2023)- Six month outcomes from the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) registry were presented today as late-breaking clinical research at ...
Irvine Calif.-based Inari Medical Inc. reported results from what it described as the largest prospective study of interventional treatment in high-risk pulmonary embolism (PE), which found a 90% ...
IRVINE, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...
SPRINGFIELD — Mercy Medical Center is the first hospital in Western Massachusetts to offer a new, non-surgical treatment option for pulmonary embolism patients with the Inari Medical’s FlowTriever ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results